CoChat

NLRP3 Inflammasome Contributes to Lipopolysaccharide-induced Depressive-Like Behaviors via Indoleamine 2,3-dioxygenase Induction

Open access
Jeon, Seon-A, Lee, Eunju, Hwang, Inhwa, Han, Boyoung, Park, Sangjun, Son, Seunghwan, Yang, Jungmin, Hong, Sujeong, Kim, Chul Hoon, Son, Junghyun, Yu, Je-Wook · 2017 · International Journal of Neuropsychopharmacology

The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.

Abstract

Background: Inflammation may play a significant role in the pathogenesis of depression, although the molecular target for the treatment of inflammation-mediated depressive symptoms remains to be elucidated. Recent studies have implicated the NLRP3 inflammasome in various psychiatric disorders, including depression. However, the underlying mechanism by which NLRP3 inflammasome activation mediates the progression of depressive-like behaviors remains poorly understood. Methods: We examined whether NLRP3 deficiency influenced depressive-like behaviors and cerebral inflammation following systemic administration of lipopolysaccharide in mice. To further assess the contribution of the NLRP3 inflammasome to the progression of depression, we evaluated the effects of NLRP3 signaling on levels of indoleamine 2,3-dioxygenase. Results: Nlrp3-deficient mice exhibited significant attenuation of depressive-like behaviors and cerebral caspase-1 activation in a lipopolysaccharide-induced model of depression. Treatment with the antidepressant amitriptyline failed to block NLRP3-dependent activation of caspase-1, but inhibited lipopolysaccharide-promoted production of interleukin-1β mRNA via suppressing NF-κB signaling in mouse mixed glial cultures. Interestingly, lipopolysaccharide administration produced NLRP3-dependent increases in indoleamine 2,3-dioxygenase expression and activity of mouse brain. Furthermore, inflammasome-activating stimulations, but not treatment with the inflammasome product interleukin-1β, triggered indoleamine 2,3-dioxygenase mRNA induction in mixed glial cells. Conclusions: Our data indicate that the NLRP3 inflammasome is significantly implicated in the progression of systemic inflammation-induced depression. NLRP3-dependent caspase-1 activation produced significant increases in indoleamine 2,3-dioxygenase levels, which may play a significant role in lipopolysaccharide-induced depression. Collectively, our findings suggest that indoleamine 2,3-dioxygenase is a potential downstream mediator of the NLRP3 inflammasome in inflammation-mediated depressive-like behaviors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ijnp/pyx065

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Depression-related behavioral tests in wild-type and Nlrp3-deficient mice upon lipopolysaccharide (LPS) administration. (A) Time schedule for behavioral tests of mice injected with PBS or LPS. (B-C) The tail suspension test (TST) (B) and forced swim test (FST) (C) were conducted with PBS- or LPS-administered mice at 24 hours (B) and 28 hours (C) post injection and analyzed. PBS (n = 11), LPS (n = 13). (D) The sucrose preference test (SPT) was conducted with PBS- or LPS-administered mice at 24 hours post administration of PBS (n = 5 cages) or LPS (n = 6 cages). (E) The open field test (OFT) was conducted with PBS- or LPS-administered mice at 24 hours post injection. PBS (n = 6), LPS (n = 6). (F) Body weights (BW) of mice were measured at 24 hours post administration, and the weight loss was displayed. PBS (n = 11), LPS (n = 13). (B-F) Data were analyzed by 2-way ANOVA with Bonferroni posthoc test. Asterisks indicate significant differences. (*P<.05; **P<.01; ***P<.001; n.s., not significant).
Figure 1. Depression-related behavioral tests in wild-type and Nlrp3-deficient mice upon lipopolysaccharide (LPS) administration. (A) Time schedule for behavioral tests of mice injected with PBS or LPS. (B-C) The tail suspension test (TST) (B) and forced swim test (FST) (C) were conducted with PBS- or LPS-administered mice at 24 hours (B) and 28 hours (C) post injection and analyzed. PBS (n = 11), LPS (n = 13). (D) The sucrose preference test (SPT) was conducted with PBS- or LPS-administered mice at 24 hours post administration of PBS (n = 5 cages) or LPS (n = 6 cages). (E) The open field test (OFT) was conducted with PBS- or LPS-administered mice at 24 hours post injection. PBS (n = 6), LPS (n = 6). (F) Body weights (BW) of mice were measured at 24 hours post administration, and the weight loss was displayed. PBS (n = 11), LPS (n = 13). (B-F) Data were analyzed by 2-way ANOVA with Bonferroni posthoc test. Asterisks indicate significant differences. (*P<.05; **P<.01; ***P<.001; n.s., not significant).CC BY-NC · PubMed Central
Figure 2. Brain inflammation in wild-type and Nlrp3-deficient mice upon lipopolysaccharide (LPS) administration. (A-B) Hippocampal regions were isolated from PBS- or LPS-administered mice at 24 hours post injection and dissociated into single cell suspensions. Cells were then stained with CD11b- and CD45-specific antibodies and analyzed via flow cytometry. The relative percentages of CD11b+CD45+ cells are plotted in B (n = 4). (C-D) Levels of IL-1β were quantified by ELISA in the brain homogenates of untreated mice and LPS-injected mice after 6 or 24 hours of administration (C, n = 4) and of PBS- or LPS-injected mice after 24 hours of administration (D, n = 8). (E) Levels of interleukin (IL)-1β were quantified by ELISA in the hippocampal homogenates of PBS- or LPS-injected mice after 24 hours post injection (n = 4). (F-G) Hippocampal regions were dissociated into single cell suspension as in (A). Cells were also stained with anti-CD11b antibody, anti-CD45 antibody, and active caspase-1-specific FLICA reagent (carboxyfluorescein-YVAD-FMK), following which they were analyzed via flow cytometry (n = 4). (B-E, G) Data were analyzed by 1-way ANOVA with Dunnett’s posthoc test (C) or 2-way ANOVA with Bonferroni posthoc test (B, D, E, G). Asterisks indicate significant differences. (*P<.05; **P<.01; *** P<.001; n.s., not significant).
Figure 2. Brain inflammation in wild-type and Nlrp3-deficient mice upon lipopolysaccharide (LPS) administration. (A-B) Hippocampal regions were isolated from PBS- or LPS-administered mice at 24 hours post injection and dissociated into single cell suspensions. Cells were then stained with CD11b- and CD45-specific antibodies and analyzed via flow cytometry. The relative percentages of CD11b+CD45+ cells are plotted in B (n = 4). (C-D) Levels of IL-1β were quantified by ELISA in the brain homogenates of untreated mice and LPS-injected mice after 6 or 24 hours of administration (C, n = 4) and of PBS- or LPS-injected mice after 24 hours of administration (D, n = 8). (E) Levels of interleukin (IL)-1β were quantified by ELISA in the hippocampal homogenates of PBS- or LPS-injected mice after 24 hours post injection (n = 4). (F-G) Hippocampal regions were dissociated into single cell suspension as in (A). Cells were also stained with anti-CD11b antibody, anti-CD45 antibody, and active caspase-1-specific FLICA reagent (carboxyfluorescein-YVAD-FMK), following which they were analyzed via flow cytometry (n = 4). (B-E, G) Data were analyzed by 1-way ANOVA with Dunnett’s posthoc test (C) or 2-way ANOVA with Bonferroni posthoc test (B, D, E, G). Asterisks indicate significant differences. (*P<.05; **P<.01; *** P<.001; n.s., not significant).CC BY-NC · PubMed Central
Figure 3. Effect of amitriptyline on NLRP3 inflammasome activation. (A) Mouse brain mixed glial cells were pretreated with amitriptyline (AT, 20 or 50 μM) for 1 hour, then primed with lipopolysaccharide (LPS) (0.25 μg/mL, 3 hours), followed by treatment with ATP (2 mM, 45 minutes) or nigericin (nig, 5 μM, 45 minutes). (B) Mouse bone marrow-derived macrophages (BMDMs) were pretreated with amitriptyline (AT, 10 or 50 μM) for 1 hour, then primed with LPS (0.25 μg/mL, 3 h), followed by treatment with ATP (2 mM, 45 minutes) or nigericin (nig, 5 μM, 45 minutes). (A-B) Culture supernatants (Sup) or cellular lysates (Lys) were immunoblotted with the indicated antibodies. (C-F) Mouse mixed glial cells (C, E) or BMDMs (D, F) were pretreated with amitriptyline (AT, 20 or 50 μM) for 1 hour, then primed with LPS (0.25 μg/mL, 3 hours), followed by treatment with ATP (2 mM, 45 minutes). (C-D) Culture supernatants were assayed for the quantification of IL-1β via ELISA. (E-F) Cellular lysates were assayed for the quantification of IL-1β mRNA via quantitative real-time PCR. (C-F) Data were analyzed by 1-way ANOVA with Dunnett’s posthoc test. Asterisks indicate significant differences (n = 5, C; n = 3, D; n = 3, E; n = 4, F; ***P<.001). (G) Mouse BMDMs were pretreated with amitriptyline (AT, 50 μM) for 30 minutes, followed by the treatment with LPS (0.5 μg/mL) for the indicated times. Cellular lysates were immunoblotted with the indicated antibodies. Unt: untreated.
Figure 3. Effect of amitriptyline on NLRP3 inflammasome activation. (A) Mouse brain mixed glial cells were pretreated with amitriptyline (AT, 20 or 50 μM) for 1 hour, then primed with lipopolysaccharide (LPS) (0.25 μg/mL, 3 hours), followed by treatment with ATP (2 mM, 45 minutes) or nigericin (nig, 5 μM, 45 minutes). (B) Mouse bone marrow-derived macrophages (BMDMs) were pretreated with amitriptyline (AT, 10 or 50 μM) for 1 hour, then primed with LPS (0.25 μg/mL, 3 h), followed by treatment with ATP (2 mM, 45 minutes) or nigericin (nig, 5 μM, 45 minutes). (A-B) Culture supernatants (Sup) or cellular lysates (Lys) were immunoblotted with the indicated antibodies. (C-F) Mouse mixed glial cells (C, E) or BMDMs (D, F) were pretreated with amitriptyline (AT, 20 or 50 μM) for 1 hour, then primed with LPS (0.25 μg/mL, 3 hours), followed by treatment with ATP (2 mM, 45 minutes). (C-D) Culture supernatants were assayed for the quantification of IL-1β via ELISA. (E-F) Cellular lysates were assayed for the quantification of IL-1β mRNA via quantitative real-time PCR. (C-F) Data were analyzed by 1-way ANOVA with Dunnett’s posthoc test. Asterisks indicate significant differences (n = 5, C; n = 3, D; n = 3, E; n = 4, F; ***P<.001). (G) Mouse BMDMs were pretreated with amitriptyline (AT, 50 μM) for 30 minutes, followed by the treatment with LPS (0.5 μg/mL) for the indicated times. Cellular lysates were immunoblotted with the indicated antibodies. Unt: untreated.CC BY-NC · PubMed Central
Figure 4. Effect of NLRP3 inflammasome activation on indoleamine 2,3-dioxygenase (IDO) production. (A-C) After 24 hours of PBS or lipopolysaccharide (LPS) administration, mouse brain homogenates were prepared and assayed for Ido (A) or Nlrp3 (B) mRNA levels via quantitative real-time PCR (n = 4) or employed for the quantification of kynurenine (Kyn) and tryptophan (Trp) via HPLC analysis (C) (n = 4). (D) At 24 hours post PBS or LPS injection, mouse brain hippocampal homogenates were prepared and assayed for IDO1 enzyme activity. IDO1 specific activity of samples was determined as the amount of produced N-formylkynurenine per minute per mg protein and expressed as the relative fold value compared with PBS-injected wild type mice (n = 3). (E) Mouse mixed glial cells were untreated or treated with LPS alone (0.5 μg/mL, 5 hours), LPS (0.5 μg/mL, 3 hours) followed by ATP (2 mM, 14 hours), or IFN-γ (20 ng/mL, 14 hours) (n = 4, LPS alone; n = 6). (F) Mouse mixed glial cells were untreated or treated with LPS alone (0.25 μg/mL, 3 hours), LPS (0.25 μg/mL, 3 hours) followed by ATP (2 mM, 30 minutes), or ATP alone (2 mM, 30 minutes). (n = 3) (G) Wild-type or Nlrp3-/- mice mixed glial cells were treated with LPS alone, LPS followed by ATP, or ATP alone (2 mM, 10 hours) (n = 6). (H) Mouse mixed glial cells were pretreated with amitriptyline (AT, 50 μM) for 30 minutes, treated with LPS (0.25 μg/mL, 3 hours), followed by ATP treatment (2 mM, 30 minutes). (n = 3) (E-H) Cellular lysates were assayed for the quantification of IDO mRNA via quantitative real-time PCR. Data were analyzed by 1-way ANOVA with Dunnett’s posthoc test (E-F, H) or 2-way ANOVA with Bonferroni posthoc test (A-D, G). Asterisks indicate significant differences. (*P<.05; **P<.01; ***P<.001; n.s., not significant). Unt, untreated.
Figure 4. Effect of NLRP3 inflammasome activation on indoleamine 2,3-dioxygenase (IDO) production. (A-C) After 24 hours of PBS or lipopolysaccharide (LPS) administration, mouse brain homogenates were prepared and assayed for Ido (A) or Nlrp3 (B) mRNA levels via quantitative real-time PCR (n = 4) or employed for the quantification of kynurenine (Kyn) and tryptophan (Trp) via HPLC analysis (C) (n = 4). (D) At 24 hours post PBS or LPS injection, mouse brain hippocampal homogenates were prepared and assayed for IDO1 enzyme activity. IDO1 specific activity of samples was determined as the amount of produced N-formylkynurenine per minute per mg protein and expressed as the relative fold value compared with PBS-injected wild type mice (n = 3). (E) Mouse mixed glial cells were untreated or treated with LPS alone (0.5 μg/mL, 5 hours), LPS (0.5 μg/mL, 3 hours) followed by ATP (2 mM, 14 hours), or IFN-γ (20 ng/mL, 14 hours) (n = 4, LPS alone; n = 6). (F) Mouse mixed glial cells were untreated or treated with LPS alone (0.25 μg/mL, 3 hours), LPS (0.25 μg/mL, 3 hours) followed by ATP (2 mM, 30 minutes), or ATP alone (2 mM, 30 minutes). (n = 3) (G) Wild-type or Nlrp3-/- mice mixed glial cells were treated with LPS alone, LPS followed by ATP, or ATP alone (2 mM, 10 hours) (n = 6). (H) Mouse mixed glial cells were pretreated with amitriptyline (AT, 50 μM) for 30 minutes, treated with LPS (0.25 μg/mL, 3 hours), followed by ATP treatment (2 mM, 30 minutes). (n = 3) (E-H) Cellular lysates were assayed for the quantification of IDO mRNA via quantitative real-time PCR. Data were analyzed by 1-way ANOVA with Dunnett’s posthoc test (E-F, H) or 2-way ANOVA with Bonferroni posthoc test (A-D, G). Asterisks indicate significant differences. (*P<.05; **P<.01; ***P<.001; n.s., not significant). Unt, untreated.CC BY-NC · PubMed Central
Figure 5. Inhibition of caspase-1/inflammasome attenuates indoleamine 2,3-dioxygenase (IDO) production. (A-C) Mouse mixed glial cells were treated with LPS (0.5 μg/mL) in the presence of zVAD-fmk (40 μM) or glibenclamide (100 μM) for 3 hours followed by ATP (2 mM, 15 hours). (A-B) Cellular lysates were assayed for the quantification of Ido mRNA via quantitative real-time PCR (n = 3). (C) Culture supernatants were immunoblotted with the indicated antibodies. (D-E) Mouse mixed glial cells were treated with lipopolysaccharide (LPS) (0.5 μg/mL) in the presence of zVAD-fmk (40 μM) for 3 hours followed by ATP (2 mM, 15 hours). Culture supernatants were assayed for the quantification of interleukin (IL)-1β or IL-6 via ELISA (n = 4). (F) Mouse mixed glial cells were treated with IL-1β (20 ng/ml), IL-18 (20 ng/ml), or interferon (IFN)-γ (20 ng/mL) for 20 hours (n = 3). (G) Mouse hippocampal neuronal HT-22 cells were treated with LPS alone (0.5 μg/mL, 20 hours), LPS (0.5 μg/mL, 3 hours) followed by ATP (2 mM, 20 hours), IL-1β (20 ng/mL, 20 hours), IL-18 (20 ng/mL, 20 hours), or IFN-γ (20 ng/mL, 20 hours) (n = 3). (H) Mouse mixed glial cells were transfected with poly dA:dT (1 μg/mL, 14 hours) or treated with IFN-γ (20 ng/mL) for 14 hours (n = 3). (F-H) Cellular lysates were assayed for the quantification of Ido mRNA via quantitative real-time PCR. Data were analyzed by 1-way ANOVA with Dunnett’s posthoc test. Asterisks indicate significant differences (*P<.05; **P<.01; ***P<.001; n.s., not significant). Unt, untreated.
Figure 5. Inhibition of caspase-1/inflammasome attenuates indoleamine 2,3-dioxygenase (IDO) production. (A-C) Mouse mixed glial cells were treated with LPS (0.5 μg/mL) in the presence of zVAD-fmk (40 μM) or glibenclamide (100 μM) for 3 hours followed by ATP (2 mM, 15 hours). (A-B) Cellular lysates were assayed for the quantification of Ido mRNA via quantitative real-time PCR (n = 3). (C) Culture supernatants were immunoblotted with the indicated antibodies. (D-E) Mouse mixed glial cells were treated with lipopolysaccharide (LPS) (0.5 μg/mL) in the presence of zVAD-fmk (40 μM) for 3 hours followed by ATP (2 mM, 15 hours). Culture supernatants were assayed for the quantification of interleukin (IL)-1β or IL-6 via ELISA (n = 4). (F) Mouse mixed glial cells were treated with IL-1β (20 ng/ml), IL-18 (20 ng/ml), or interferon (IFN)-γ (20 ng/mL) for 20 hours (n = 3). (G) Mouse hippocampal neuronal HT-22 cells were treated with LPS alone (0.5 μg/mL, 20 hours), LPS (0.5 μg/mL, 3 hours) followed by ATP (2 mM, 20 hours), IL-1β (20 ng/mL, 20 hours), IL-18 (20 ng/mL, 20 hours), or IFN-γ (20 ng/mL, 20 hours) (n = 3). (H) Mouse mixed glial cells were transfected with poly dA:dT (1 μg/mL, 14 hours) or treated with IFN-γ (20 ng/mL) for 14 hours (n = 3). (F-H) Cellular lysates were assayed for the quantification of Ido mRNA via quantitative real-time PCR. Data were analyzed by 1-way ANOVA with Dunnett’s posthoc test. Asterisks indicate significant differences (*P<.05; **P<.01; ***P<.001; n.s., not significant). Unt, untreated.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 44 references

Cited by

See all 62

Metadata

Authors
Jeon, S.-A., Lee, E., Hwang, I., Han, B., Park, S., Son, S., Yang, J., Hong, S., Kim, C. H., Son, J., & Yu, J.-W.
Affiliations
Yonsei University (KR)
Corresponding author
Yu, Je-Wook
Venue
International Journal of Neuropsychopharmacology
Published
2017-07-31
Volume
20
Issue
11
Pages
896-906
ISSN
  • 1461-1457 (ISSN-L)
  • 1469-5111
OpenAlex
W2741260697
Cited by
62
References
44
Citations by year
2026: 4 · 2025: 9 · 2024: 12 · 2023: 4 · 2022: 6 · 2021: 6 · 2020: 8 · 2019: 11 · 2018: 2
FWCI
1.91
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
Funders
National Research Foundation of Korea (2014R1A4A1008625, 2017R1A2B2007467)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
NLRP3 inflammasome, depression, lipopolysaccharide, indoleamine 2,3-dioxygenase, caspase-1, IL-1β, NF-κB signaling, systemic inflammation, depression-like behavior, amitriptyline, neuroinflammation
MeSH terms
NLR Family, Pyrin Domain-Containing 3 Protein, Amitriptyline, Analysis of Variance, Animals, Brain, Cells, Cultured, Depression, Disease Models, Animal, Dose-Response Relationship, Drug, Enzyme Activation, Lipopolysaccharides, Mice, Inbred C57BL, Neuroglia, RNA, Messenger, Gene Expression Regulation, Enzymologic, Cytokines, Mice, Knockout, Caspase 1, Indoleamine-Pyrrole 2,3,-Dioxygenase, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: NLRP3 Inflammasome Contributes to Lipopolysaccharide-induced Depressive-Like Behaviors via Indoleamine 2,3-dioxygenase Induction. https://app.cochat.ai/papers/10.1093/ijnp/pyx065
The paper
Jeon, S.-A., Lee, E., Hwang, I., Han, B., Park, S., Son, S., Yang, J., Hong, S., Kim, C. H., Son, J., & Yu, J.-W. (2017). NLRP3 Inflammasome Contributes to Lipopolysaccharide-induced Depressive-Like Behaviors via Indoleamine 2,3-dioxygenase Induction. International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyx065

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.